التداخل بين حمض الإيثاكرينيك وزيبراسيدون

Hypokalemia may result from diuretic therapy, diarrhea, and other causes.

It is essential to periodically monitor serum electrolytes in patients for whom diuretic therapy is introduced during ziprasidone treatment.

Ziprasidone should be used with particular caution in patients with known cardiovascular disease (history of myocardial infarction or ischemic heart disease, heart failure or conduction abnormalities), cerebrovascular disease, or conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications).

Patients who are started on diuretics during Ziprasidone therapy need periodic monitoring of serum potassium and magnesium.

• Because of its potential for inducing hypotension, ziprasidone may enhance the effects of certain antihypertensive agents.